Life Science Instrumentation Market (Technique: Spectroscopy, Chromatography, Polymerase Chain Reaction, Next-generation Sequencing, Clinical Chemistry Analyzers, Flow Cytometry, Immunoassays, and Others) - Global Industry Analysis, Size, Share, Growth, T

Life Science Instrumentation Market (Technique: Spectroscopy, Chromatography, Polymerase Chain Reaction, Next-generation Sequencing, Clinical Chemistry Analyzers, Flow Cytometry, Immunoassays, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Life Science Instrumentation Market – Scope of Report
TMR’s report on the global life science instrumentation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global life science instrumentation market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global life science instrumentation market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the life science instrumentation market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global life science instrumentation market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global life science instrumentation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global life science instrumentation market.

The report delves into the competitive landscape of the global life science instrumentation market. Key players operating in the global life science instrumentation market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global life science instrumentation market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market life science instrumentation.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Life Science Instrumentation Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Life Science Instrumentation Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Reimbursement Scenario, by Region/globally
5.2. Key Mergers & Acquisitions
5.3. Technological Advancement
6. Global Life Science Instrumentation Market Analysis and Forecast, by Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Technique, 2017–2031
6.3.1. Spectroscopy
6.3.2. Chromatography
6.3.3. Polymerase Chain Reaction
6.3.4. Next-generation Sequencing
6.3.5. Clinical Chemistry Analyzers
6.3.6. Flow Cytometry
6.3.7. Immunoassays
6.3.8. Others
6.4. Market Attractiveness Analysis, by Technique
7. Global Life Science Instrumentation Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Research Applications
7.3.2. Clinical Applications
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Life Science Instrumentation Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Research Institutes
8.3.2. Pharmaceutical & Biotechnology Companies
8.3.3. Diagnostic Laboratories
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Life Science Instrumentation Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Life Science Instrumentation Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technique, 2017–2031
10.2.1. Spectroscopy
10.2.2. Chromatography
10.2.3. Polymerase Chain Reaction
10.2.4. Next-generation Sequencing
10.2.5. Clinical Chemistry Analyzers
10.2.6. Flow Cytometry
10.2.7. Immunoassays
10.2.8. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Research Applications
10.3.2. Clinical Applications
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.4.3. Diagnostic Laboratories
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technique
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Life Science Instrumentation Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Technique, 2017–2031
11.2.1. Spectroscopy
11.2.2. Chromatography
11.2.3. Polymerase Chain Reaction
11.2.4. Next-generation Sequencing
11.2.5. Clinical Chemistry Analyzers
11.2.6. Flow Cytometry
11.2.7. Immunoassays
11.2.8. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Research Applications
11.3.2. Clinical Applications
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.4.3. Diagnostic Laboratories
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technique
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Life Science Instrumentation Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Technique, 2017–2031
12.2.1. Chromatography
12.2.2. Polymerase Chain Reaction
12.2.3. Next-generation Sequencing
12.2.4. Clinical Chemistry Analyzers
12.2.5. Flow Cytometry
12.2.6. Immunoassays
12.2.7. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Research Applications
12.3.2. Clinical Applications
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.4.3. Diagnostic Laboratories
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technique
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Life Science Instrumentation Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Technique, 2017–2031
13.2.1. Spectroscopy
13.2.2. Chromatography
13.2.3. Polymerase Chain Reaction
13.2.4. Next-generation Sequencing
13.2.5. Clinical Chemistry Analyzers
13.2.6. Flow Cytometry
13.2.7. Immunoassays
13.2.8. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Research Applications
13.3.2. Clinical Applications
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.4.3. Diagnostic Laboratories
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technique
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Life Science Instrumentation Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Technique, 2017–2031
14.2.1. Spectroscopy
14.2.2. Chromatography
14.2.3. Polymerase Chain Reaction
14.2.4. Next-generation Sequencing
14.2.5. Clinical Chemistry Analyzers
14.2.6. Flow Cytometry
14.2.7. Immunoassays
14.2.8. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Research Applications
14.3.2. Clinical Applications
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Research Institutes
14.4.2. Pharmaceutical & Biotechnology Companies
14.4.3. Diagnostic Laboratories
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technique
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Company Profiles
15.1.1. Danaher
15.1.1.1. Company Overview
15.1.1.2. Product Portfolio
15.1.1.3. SWOT Analysis
15.1.1.4. Financial Overview
15.1.1.5. Strategic Overview
15.1.2. Thermo Fisher Scientific, Inc.
15.1.2.1. Company Overview
15.1.2.2. Product Portfolio
15.1.2.3. SWOT Analysis
15.1.2.4. Financial Overview
15.1.2.5. Strategic Overview
15.1.3. Merck KGaA
15.1.3.1. Company Overview
15.1.3.2. Product Portfolio
15.1.3.3. SWOT Analysis
15.1.3.4. Financial Overview
15.1.3.5. Strategic Overview
15.1.4. Bio-Rad Laboratories, Inc.
15.1.4.1. Company Overview
15.1.4.2. Product Portfolio
15.1.4.3. SWOT Analysis
15.1.4.4. Financial Overview
15.1.4.5. Strategic Overview
15.1.5. Agilent Technologies, Inc.
15.1.5.1. Company Overview
15.1.5.2. Product Portfolio
15.1.5.3. SWOT Analysis
15.1.5.4. Financial Overview
15.1.5.5. Strategic Overview
15.1.6. Illumina, Inc.
15.1.6.1. Company Overview
15.1.6.2. Product Portfolio
15.1.6.3. SWOT Analysis
15.1.6.4. Financial Overview
15.1.6.5. Strategic Overview
15.1.7. PerkinElmer, Inc.
15.1.7.1. Company Overview
15.1.7.2. Product Portfolio
15.1.7.3. SWOT Analysis
15.1.7.4. Financial Overview
15.1.7.5. Strategic Overview
15.1.8. BD
15.1.8.1. Company Overview
15.1.8.2. Product Portfolio
15.1.8.3. SWOT Analysis
15.1.8.4. Financial Overview
15.1.8.5. Strategic Overview
15.1.9. Bruker
15.1.9.1. Company Overview
15.1.9.2. Product Portfolio
15.1.9.3. SWOT Analysis
15.1.9.4. Financial Overview
15.1.9.5. Strategic Overview
15.1.10. Hitachi High-Technologies Corporation
15.1.10.1. Company Overview
15.1.10.2. Product Portfolio
15.1.10.3. SWOT Analysis
15.1.10.4. Financial Overview
15.1.10.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings